$12.5B
$1.5 Billion
0.06% of portfolio
7,558
Q2 2025
Added 53.34%
-
$1.45 Billion
0.05% of portfolio
-
Q2 2025
New
$27.4B
$1.21 Billion
0.05% of portfolio
19,181
Q2 2025
Added 31.48%
$10.5B
$1.28 Billion
0.05% of portfolio
5,286
Q2 2025
Added 343.83%
$15.7B
$1.24 Billion
0.05% of portfolio
35,973
Q2 2025
Reduced 38.35%
-
$1.23 Billion
0.05% of portfolio
-
Q2 2025
New
$136B
$1.28 Billion
0.05% of portfolio
3,653
Q2 2025
Reduced 59.43%
$7.05B
$1.33 Billion
0.05% of portfolio
15,454
Q2 2025
Added 148.5%
$13B
$1.28 Billion
0.05% of portfolio
32,041
Q2 2025
Reduced 67.86%
$10.5B
$1.39 Billion
0.05% of portfolio
15,514
Q2 2025
Reduced 17.69%
$11.9B
$1.25 Billion
0.05% of portfolio
13,895
Q2 2025
New
$25.1B
$1.2 Billion
0.05% of portfolio
76,500
Q2 2025
New
$15.7B
$1.22 Billion
0.05% of portfolio
11,143
Q2 2025
New
$5.28B
$1.03 Billion
0.04% of portfolio
12,997
Q2 2025
New
$14.4B
$950 Million
0.04% of portfolio
5,573
Q2 2025
Added 1,763.88%
$6.76B
$947 Million
0.04% of portfolio
27,358
Q2 2025
Added 1,155.53%
$71.7B
$1.07 Billion
0.04% of portfolio
1,345
Q2 2025
New
-
$1.1 Billion
0.04% of portfolio
-
Q2 2025
New
$14.5B
$1.12 Billion
0.04% of portfolio
3,292
Q2 2025
New
$14.1B
$1.05 Billion
0.04% of portfolio
12,971
Q2 2025
Added 134.01%
$5.84B
$994 Million
0.04% of portfolio
21,112
Q2 2025
Added 29.56%
$4.78B
$990 Million
0.04% of portfolio
10,584
Q2 2025
Reduced 15.27%
$15.9B
$1.18 Billion
0.04% of portfolio
7,153
Q2 2025
New
$26.8B
$1.09 Billion
0.04% of portfolio
12,441
Q2 2025
Reduced 76.58%
$146B
$963 Million
0.04% of portfolio
4,135
Q2 2025
Reduced 89.87%
$5.25B
$1.12 Billion
0.04% of portfolio
19,346
Q2 2025
New
$17B
$1.01 Billion
0.04% of portfolio
3,284
Q2 2025
New
$6.86B
$1.16 Billion
0.04% of portfolio
9,360
Q2 2025
New
$3.68B
$937 Million
0.04% of portfolio
11,782
Q2 2025
New
$58.4B
$1 Billion
0.04% of portfolio
23,307
Q2 2025
Reduced 86.98%
$6.87B
$959 Million
0.04% of portfolio
21,681
Q2 2025
Reduced 79.29%
-
$951 Million
0.04% of portfolio
-
Q2 2025
New
$7.61B
$867 Million
0.03% of portfolio
11,616
Q2 2025
New
$6.37B
$774 Million
0.03% of portfolio
16,090
Q2 2025
Added 646.29%
$6.9B
$718 Million
0.03% of portfolio
4,987
Q2 2025
New
$6.74B
$751 Million
0.03% of portfolio
26,458
Q2 2025
New
$3.47B
$817 Million
0.03% of portfolio
51,116
Q2 2025
Added 63,006.17%
$6.95B
$876 Million
0.03% of portfolio
16,741
Q2 2025
Added 119.24%
$10.4B
$703 Million
0.03% of portfolio
3,024
Q2 2025
New
$25.8B
$717 Million
0.03% of portfolio
5,542
Q2 2025
New
$4.76B
$783 Million
0.03% of portfolio
62,982
Q2 2025
Added 818.64%
Ascentage Pharma Group Intl
-
$823 Million
0.03% of portfolio
-
Q2 2025
Reduced 17.77%
$8.86B
$760 Million
0.03% of portfolio
4,681
Q2 2025
Added 27.83%
$40.9B
$806 Million
0.03% of portfolio
7,576
Q2 2025
Reduced 85.81%
$17.6B
$886 Million
0.03% of portfolio
12,808
Q2 2025
New
$7.05B
$911 Million
0.03% of portfolio
6,521
Q2 2025
Added 24.64%
$122B
$704 Million
0.03% of portfolio
8,072
Q2 2025
Reduced 94.64%
$6.28B
$804 Million
0.03% of portfolio
37,683
Q2 2025
New
$3.81B
$905 Million
0.03% of portfolio
428,777
Q2 2025
New
$6.72B
$923 Million
0.03% of portfolio
16,964
Q2 2025
Added 244.1%